financetom
Business
financetom
/
Business
/
Hearst makes ‘best and final’ bid for DallasNews Corporation ahead of shareholder vote [The Dallas Morning News]
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hearst makes ‘best and final’ bid for DallasNews Corporation ahead of shareholder vote [The Dallas Morning News]
Sep 15, 2025 6:28 PM

Hearst increased its bid for DallasNews Corporation ( DALN ) once more as the deal heads to the conclusion of a shareholder vote Sept. 23.

On Monday, DallasNews Corporation ( DALN ) issued a news release stating Hearst upped its all-cash bid for the company from $15 per share to $16.50 per share, a “significant premium” of 276% from where the company’s stock traded in early July, when the deal was made public.

DallasNews Corporation ( DALN ) is the public parent company of The Dallas Morning News and Medium Giant, an integrated creative marketing agency, with offices in Dallas and Tulsa.

“With this best and final increase to our offer, we are clearly demonstrating our commitment to providing significant value to DallasNews ( DALN ) shareholders and further illustrating our belief that DallasNews ( DALN ) has a bright future as part of the Hearst family,” Jeff Johnson, president of Hearst Newspapers, said in a statement.

Hearst is a diverse media company with a portfolio of 28 daily newspapers, including the Houston Chronicle, San Antonio Express-News and Austin American-Statesman, and 50 weeklies.

In addition, Hearst owns 35 television stations and more than 200 magazines and has an ownership stake in cable networks A&E, HISTORY, Lifetime and ESPN ( DIS ). Outside of media, Hearst owns Fitch Group, a global financial services business; Hearst Transportation; and Hearst Health, a group of medical information and services businesses.

The shareholder voting window is already open.

John A. Beckert, chairman of the DallasNews Corporation ( DALN ) board, framed the decision for shareholders in a statement: “DallasNews shareholders have an important choice to make: either support this value creating transaction and realize a significant premium on their investment, or alternatively, DallasNews ( DALN ) will remain a public company and its shares may return to their pre-announcement trading value of approximately $4 per share.”

Monday was the second time in a month Hearst has increased its offer following an unsolicited bid by MNG Enterprises Inc., an affiliate of Alden Global Capital.

Hearst originally offered $14 per share. MediaNews Group has offered $18.50 per share.

Alden Global Capital’s MediaNews Group owns 77 daily newspapers and more than 150 weekly publications across the country, including the Chicago Tribune, The Denver Post, The Mercury News, The Virginian-Pilot and Boston Herald.

MediaNews Group’s bid has been firmly rebuffed by controlling shareholder Robert W. Decherd, a great-grandson of co-founder George Bannerman Dealey who holds the majority of voting power in the company. The DallasNews Corporation’s board of directors has directly stated that without Decherd, who controls 55% of the total voting power, Alden’s bid has no standing.

“Decherd has publicly and consistently stated that he will vote for the Hearst Merger based on Hearst’s reputation and historic commitment to journalistic integrity, delivering high-quality local news, and meeting its audiences’ information needs with excellence,” the statement from DallasNews Corporation ( DALN ) said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca's Imfinzi Granted Priority Review in US as Muscle-Invasive Bladder Cancer Treatment
AstraZeneca's Imfinzi Granted Priority Review in US as Muscle-Invasive Bladder Cancer Treatment
Dec 6, 2024
07:35 AM EST, 12/06/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Friday that the US Food and Drug Administration granted priority review for a supplemental biologics license application for Imfinzi as a treatment for patients with muscle-invasive bladder cancer. The company said a priority review is granted to applications for medicines that would offer significant improvements over other treatment...
BMO on The Day Ahead in Canada
BMO on The Day Ahead in Canada
Dec 6, 2024
07:33 AM EST, 12/06/2024 (MT Newswires) -- Canada will release its Labour Force Survey (LFS) for November at 8:30 a.m. ET on Friday, noted Bank of Montreal (BMO). Canadian employment growth is expected to improve to 20,000 in November -- consensus at 25,000 -- after slowing to 14,500 in October, noted the bank. Annual average hourly wage gains look to...
Update: Encompass Health, Enhabit Win Breach of Fiduciary Duty Lawsuit
Update: Encompass Health, Enhabit Win Breach of Fiduciary Duty Lawsuit
Dec 6, 2024
07:34 AM EST, 12/06/2024 (MT Newswires) -- (Updates to add Nautic and Vistria Group's joint statement in the fifth paragraph and the recent stock movement in the seventh paragraph.) Encompass Health ( EHC ) and Enhabit ( EHAB ) said Wednesday the Delaware Court of Chancery awarded them damages and other remedies related to a lawsuit against former executives and...
CRH Names Alan Connolly Interim CFO
CRH Names Alan Connolly Interim CFO
Dec 6, 2024
07:30 AM EST, 12/06/2024 (MT Newswires) -- CRH (CRH) said Friday it has named Alan Connolly interim chief financial officer, effective Jan. 1. Connolly will succeed current CFO Jim Mintern, who will assume the chief executive role, the company said. Connolly was previously the director of strategic finance, said CRH, which is actively searching for a permanent successor. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved